Status:

Red

Decision Date:

February 2022

Comments

RED: NICE TA754 - Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome. (Decision date -  February 2022)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again